Shares of Ambu A/S (OTCMKTS:AMBBY – Get Free Report) traded up 1.5% on Thursday . The company traded as high as $20.24 and last traded at $19.78. 250 shares were traded during mid-day trading, an increase of 197% from the average session volume of 84 shares. The stock had previously closed at $19.50.
Ambu A/S Stock Performance
The company has a quick ratio of 1.47, a current ratio of 2.60 and a debt-to-equity ratio of 0.08. The stock has a 50 day simple moving average of $16.95 and a two-hundred day simple moving average of $18.00. The stock has a market capitalization of $4.65 billion and a P/E ratio of 116.38.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.10 earnings per share for the quarter. Ambu A/S had a return on equity of 5.67% and a net margin of 5.69%.
About Ambu A/S
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Featured Stories
- Five stocks we like better than Ambu A/S
- How Can Investors Benefit From After-Hours Trading
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Where Do I Find 52-Week Highs and Lows?
- DuPont’s Electronics Spinoff: The Start of Something Big
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
